TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Dec. 6, 2023 VANCOUVER, BC, Dec. 6, 2023 /CNW/ -TSX VENTURE...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - PSYB Canada NewsWire VANCOUVER, BC...
Canadian Investment Regulatory Organization Trading Halt - PSYB Canada NewsWire VANCOUVER, BC, Dec. 6, 2023 VANCOUVER, BC, Dec. 6, 2023 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - PSYB Canada NewsWire VANCOUVER, BC, Nov. 27, 2023 VANCOUVER, BC, Nov. 27, 2023 /CNW/...
PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert Toad as it Files Three New...
PsyBio Therapeutics Files Four U.S. Patent Cooperation Treaty (PCT) Patent Applications Further Expanding Its...
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing Canada NewsWire OXFORD, Ohio and...
PsyBio Therapeutics Reports Third Quarter 2022 Financial Results Canada NewsWire OXFORD, Ohio and DENVER, Nov...
PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial Canada NewsWire OXFORD, OH...
PsyBio Therapeutics Latest U.S. PCT (Non-Provisional) Patent Application Accepted Canada NewsWire OXFORD, OH...
PsyBio Therapeutics to Present at Upcoming Investor Events in September 2022 Canada NewsWire OXFORD, Ohio and...
PsyBio Therapeutics Reports Second Quarter 2022 Financial Results Canada NewsWire OXFORD, OH and DENVER, CO...
PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support Previously Submitted...
PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent Applications Canada...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads